🔎 Trials Near Me

首页 › 多发性骨髓瘤 › 北卡罗来纳州 › Winston-Salem

Winston-Salem NC 多发性骨髓瘤临床试验

14项针对 多发性骨髓瘤的研究正在 Winston-Salem及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。

官方研究文本（英文）

正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

招募中3 期
  • Research Site, Winston-Salem
  • Research Site, Winston-Salem
18 岁及以上 · 所有性别 · 更新于 2026年9月29日 · NCT07391657

A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel

招募中2 期
  • Wake Forest University Baptist Medical Center (WFUBMC) - Comprehensive Cancer Center, Winston-Salem
18 至 80 岁 · 所有性别 · 更新于 2026年9月25日 · NCT07149857

Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study

招募中2 期
  • Wake Forest University, School of Medicine Dept. of Internal Medicine, Division of Hematology Oncology, Winston-Salem
60 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT06052826

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

招募中3 期
  • Novant Health Forsyth Medical Center, Winston-Salem
  • Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT05552222

A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

招募中1/2 期
  • Wake Forest Baptist Health /ID# 271294, Winston-Salem
18 岁及以上 · 所有性别 · 更新于 2026年9月14日 · NCT06953960

Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma

招募中3 期
  • Forsythe Memorial Hospital Inc., dba Novant Health Oncology Specialists, Winston-Salem
18 岁及以上 · 所有性别 · 更新于 2026年9月11日 · NCT07555938

Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT

招募中3 期
  • Research Site, Winston-Salem
  • Research Site, Winston-Salem
18 岁及以上 · 所有性别 · 更新于 2026年8月14日 · NCT07764978

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations

招募中1/2 期
  • Atrium Health Wake Forest Baptist Medical Center /ID# 274847, Winston-Salem
18 岁及以上 · 所有性别 · 更新于 2026年7月21日 · NCT06892522

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

招募中1 期
  • Atrium Health Wake Forest Baptist Medical Center /ID# 251165, Winston-Salem
18 岁及以上 · 所有性别 · 更新于 2026年7月13日 · NCT05650632

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments

招募中1 期
  • Wake Forest University Health Sciences, Winston-Salem
18 岁及以上 · 所有性别 · 更新于 2026年7月8日 · NCT05137054

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

招募中3 期
  • GSK Investigational Site, Winston-Salem
18 岁及以上 · 所有性别 · 更新于 2026年4月22日 · NCT06679101

The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen

招募中观察性研究
  • Wake Forest Baptist Health, Winston-Salem
18 至 120 岁 · 所有性别 · 更新于 2026年4月13日 · NCT01890486

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

招募中1/2 期
  • Atrium Wake Forest Baptist Medical Center, Winston-Salem
12 岁及以上 · 所有性别 · 更新于 2026年3月24日 · NCT04988555

IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

招募中1/2 期
  • Atrium Health Wake Forest Baptist, Winston-Salem
18 岁及以上 · 所有性别 · 更新于 2025年6月3日 · NCT06119685

其他城市的 多发性骨髓瘤试验

Winston-Salem的其他研究

数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。